idarucizumab,dabigatran
Boehringer Ingelheim Pharmaceuticals, Inc.
 thanks to stefan lorenzl for introducing #palliativecare #parkinson #ean2022 
Parkinson and Movement Disorders Unit - Neurology Clinic Padua University of Padua https://t.co/mGybVRjb0v